mHealth to Improve the Experience, Adherence to Drug Treatment and Positive Mental Health

December 29, 2022 updated by: Gemma Marcos, Hospital Clinic of Barcelona

mHealth to Improve the Experience, Adherence to Drug Treatment and Positive Mental Health of Patients Diagnosed With Femur Fracture: Protocol for a Quasi-experimental Study

The present study aims to evaluate the effectiveness of a pharmacological nursing educational intervention (EFE) with "Myplan Aplication" about the patient's experience, adherence to pharmacological treatment, and positive mental health of patients with femur fracture.

Study Overview

Detailed Description

Once the informed consent has been obtained, the investigators will explain to the patient the pharmacological treatment with the support of an aplication (what it is for, how the medication should be taken, possible adverse effects), also the investigators will share time with the patient during the 4 face-to-face training sessions. The investigators will accompany during their hospital stay, offering to pacients telematic support upon discharge with the treatment and until the end of the study. This is a quasi-experimental non-randomized study with 3 phases of data collection. Possible adverse reactions, if any, will be recorded.

Study Type

Interventional

Enrollment (Anticipated)

278

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Barcelona, Spain, 08036
        • Recruiting
        • Hospital Clinic De Barcelona
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • diagnosis of femur fracture
  • knowledge of the Spanish language
  • 24-hour admission to the traumatology unit
  • level of consciousness on the Glasgow scale of 15
  • have access to a mobile device
  • ability to participate in the pilot study
  • be able to provide written informed consent or obtain consent from a legal representative.

Exclusion Criteria:

  • presence of psychological pathologies or cognitive impairment
  • isolation in hospital admission

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Non-Randomized
  • Interventional Model: Single Group Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Patient experience
Inform the patient of the medication that is being taken and how it has to be taken; What is it for and the side effects and/or adverse reactions.
Review of the use of the aplication
  • How do you feel?
  • Sad feelings and frustration.
  • Achievements day by day, think positive.
  • Importance of interpersonal relationships.
  • Explain activities to relax the mind
Active Comparator: Adherence to drug treatment
Inform the patient of the medication that is being taken and how it has to be taken; What is it for and the side effects and/or adverse reactions.
Review of the use of the aplication
Active Comparator: Positive mental health
  • How do you feel?
  • Sad feelings and frustration.
  • Achievements day by day, think positive.
  • Importance of interpersonal relationships.
  • Explain activities to relax the mind

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient experience questionnaire-15. Changes in outcomes are assessed at three time points.
Time Frame: at 1rst day (before intervention), at 7th day (at discharge after intervention), and 25th day (after discharge)
This questionnaire allows us to explore the perception of patients about the information process and participation in decision-making during hospital admission. The responses range is from always or almost always/quite frequently/sometimes/never or almost never.This questionnaire allows us to explore the perception of patients about the information process and participation in decision-making during hospital admission. The responses range from always or almost always/quite frequently/sometimes/never or almost never.
at 1rst day (before intervention), at 7th day (at discharge after intervention), and 25th day (after discharge)
Morinski-Green Questionnaire. Changes in outcomes are assessed at three time points.
Time Frame: at 1rst day, at 7th day and 25th day.
This questionnaire allows assessing adherence to the prescribed treatment. It consists of a series of 4 dichotomous yes/no questions that reflects the degree of behavior of the patient's compliance, information on the causes of non-compliance.
at 1rst day, at 7th day and 25th day.
Positive Mental Health Questionnaire. Changes in outcomes are assessed at three time points.
Time Frame: at 1rst day, at 7th day and 25th day.
This scale evaluates mental health from a positive perspective. It consists of 39 items distributed in six factors: personal satisfaction, pro-social attitude, self-control, autonomy, problem solving and self-acting, and interpersonal relationship skills. Its measurement is carried out by means of a Likert-type response that goes from always or almost always, quite frequently, sometimes, never or almost never. Validated in the general population in favorable psychometric values: global reliability of 0.88 and an applied variance of 45%.
at 1rst day, at 7th day and 25th day.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Carmen Moreno Arroyo, UB

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 21, 2022

Primary Completion (Anticipated)

January 1, 2023

Study Completion (Anticipated)

April 1, 2023

Study Registration Dates

First Submitted

December 2, 2022

First Submitted That Met QC Criteria

December 29, 2022

First Posted (Actual)

December 30, 2022

Study Record Updates

Last Update Posted (Actual)

December 30, 2022

Last Update Submitted That Met QC Criteria

December 29, 2022

Last Verified

December 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

  • Publication of an article with preliminary results in the BioMed Central Public Health magazine.
  • Presentation of results at National Congress of Mental Health Nursing. Spain.
  • Publication of results article in "Revista Española de Enfermería de Salud Mental" magazine.
  • Presentation of results at Investen, Annual Meeting on Care Research. Spain.

IPD Sharing Time Frame

February 2024

IPD Sharing Access Criteria

Healthcare professionals

IPD Sharing Supporting Information Type

  • Study Protocol
  • Statistical Analysis Plan (SAP)
  • Clinical Study Report (CSR)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fracture of Femur

Clinical Trials on Pharmacological education

Subscribe